1. Japan Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Premier Anti-Aging Co., Ltd.

Premier Anti-Aging Co., Ltd.

TTSE:4934
573.00
JPY
0.00
(0.00%)
7.01BMarket Cap
Dec 11Next Earn
Premier Anti-Aging Co., Ltd.
TSE:4934
(Tokyo Stock Exchange)

Recent

price

573.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
JPY
571.78
1,370.79
2,357.18
3,839.32
3,888.86
3,027.39
2,334.65
- -
- -
Revenue per Share
10.97
20.04
131.43
326.87
163.35
-84.06
-170.06
- -
- -
Basic EPS, GAAP
2.76
-31.61
22.57
313.38
-404.31
188.52
-45.3
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
15.18
35.22
166.65
791.65
957.3
872.44
702.03
- -
769.23
Book Value per Share
8.76
27.97
156.26
774.49
926.77
699.17
587.47
- -
656.97
Tangible Book Value per Share
9
9
9
9
9
9
9
9
9
Basic Weighted Avg Shares
4,974
11,926
20,507
32,813
33,912
26,400
20,359
- -
- -
Sales/Revenue/Turnover
2.78
2.03
8.06
14.26
7.12
-2.32
0.68
- -
- -
Operating Margin (%)
11
30
32
44
85
208
250
- -
- -
Depreciation Expense
95
174
1,143
2,794
1,424
-733
-1,483
- -
- -
Net Income, GAAP
35.39
25.84
30.11
39.96
44.63
- -
- -
- -
- -
Effective Tax Rate (%)
1.92
1.46
5.58
8.51
4.2
-2.78
-7.28
- -
- -
Profit Margin (%)
176
432
1,743
6,888
8,296
6,213
5,123
- -
5,550
Working Capital
174
284
633
546
701
1,436
1,023
- -
881
LT Debt
132
306
1,450
6,903
8,348
7,608
6,122
- -
6,708
Total Equity
- -
18.8
42.49
39.82
13.38
- -
- -
- -
- -
Return on Invested Capital (%)
- -
20.29
48.52
49.8
16.3
- -
- -
- -
- -
Return on Capital (%)
- -
79.51
130.21
66.89
18.68
-9.19
-21.6
- -
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Apr'24
Jul'24
Jan'25
ST Debt
1,386
1,419
897
LT Borrowings
1,103
1,023
881
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
6,880
7,552
7,011

Working Capital

JPY

•

in mil. unless spec.
Apr'24
Jul'24
Jan'25
Total Current Assets
8,958
8,882
8,872
Cash, Cash Equivalents & STI
4,482
4,760
5,308
Accounts Receivable, Net
1,652
1,727
1,272
Inventories
1,954
1,586
1,717
Total Current Liabilities
3,766
3,759
3,322
Payables & Accruals
- -
- -
- -
ST Debt
1,386
1,419
897
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5,264
5,385
4,790
4,920
20,359
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-4.01
-189.21
26.95
-3.78
-170.06
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Premier Anti-Aging Co., Ltd. engages in the planning, development, import, export, mail order, wholesale, and retail of cosmetics and health foods primarily in Japan. The company offers an extensive range of anti-aging products including skin care, hair care, and inner care items under brands such as DUO, CANADEL, Immuno, Sitrana, and Clayence. Its product portfolio comprises high-performance aging care cosmetics, aggressive vitamin C skincare, hair aging care utilizing "The Clay Spa Method," supplements using advanced liposome technology, and self-care products based on fast beauty medical concepts. Founded in 2009 and headquartered in Tokyo, the company also provides information and consulting services related to anti-aging, beauty, and health, and manages beauty clinics and research activities. Recent major developments include the acquisition completion of Venex Co., Ltd. announced in early 2023 and a strategic expansion across anti-aging business areas including skin care, hair care, and inner care, with product launches rolled out throughout 2025. The company reports a fourfold increase in operating profit for the fiscal year ending July 2025 driven by efficient management of sales expenses and continues to focus on innovation and market expansion in the Japanese cosmetics and health food sector. Premier Anti-Aging maintains its leadership within the consumer non-cyclicals personal products industry segment through multi-channel sales including e-commerce, wholesale, and retail operations across Japan.